載入...
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
BACKGROUND: The relative efficacy and safety of intravitreous aflibercept, bevacizumab, and ranibizumab in the treatment of diabetic macular edema are unknown. METHODS: At 89 clinical sites, we randomly assigned 660 adults (mean age, 61±10 years) with diabetic macular edema involving the macular cen...
Na minha lista:
| 發表在: | N Engl J Med |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4422053/ https://ncbi.nlm.nih.gov/pubmed/25692915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1414264 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|